Advanced search
Publication Cover
Vascular Health and Risk Management Volume 10, 2014 - Issue
Submit an article Journal homepage
183
Views
2
CrossRef citations to date
0
Altmetric
Review

Macitentan for the treatment of pulmonary arterial hypertension

Cyrus A Kholdani1 Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA
,
Wassim H Fares2 Yale Pulmonary Vascular Disease Program, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
&
Terence K Trow2 Yale Pulmonary Vascular Disease Program, Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USACorrespondence[email protected]
Pages 665-673 | Published online: 25 Nov 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alexandra K Wong & Richard N Channick. (2019) Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update. Drug, Healthcare and Patient Safety 11, pages 71-85.
Read now
Isabel S Bazan & Wassim H Fares. (2015) Pulmonary hypertension: diagnostic and therapeutic challenges. Therapeutics and Clinical Risk Management 11, pages 1221-1233.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.